Our data thus far indicate that IL-4/13 are needed for atherosclerosis resolution, and the source of these cytokines is not from cells that are newly recruited in the resolution phase, but from cells accumulating during the disease progression phase. This evidence concerns the gene IL4 and atherosclerosis.